Cite
HARVARD Citation
Deng, H. et al. (2020). Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non–small-cell lung cancer. Medicine. 99 (25), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Deng, H. et al. (2020). Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non–small-cell lung cancer. Medicine. 99 (25), p. . [Online].